Table 2. Factors affecting lipiodol deposition.
Independent variable | P-value | OR | 95% CI | |
---|---|---|---|---|
Age | 0.627 | 1.006 | 0.983 | 1.029 |
Gender | 0.756 | 1.147 | 0.483 | 2.722 |
ECOG | 0.582 | 0.857 | 0.495 | 1.484 |
Child-Pugh class | 0.252 | 1.585 | 0.721 | 3.486 |
BCLC | 0.248 | 0.675 | 0.347 | 1.314 |
HbsAg | 0.815 | 0.869 | 0.268 | 2.817 |
AFP | 0.111 | 0.631 | 0.358 | 1.112 |
Tumor size | 0.679 | 1.236 | 0.453 | 3.367 |
No. of tumors | 0.486 | 0.812 | 0.453 | 1.457 |
TACE times | 0.958 | 0.984 | 0.532 | 1.820 |
GROUP | 0.041 | 0.449 | 0.208 | 0.968 |
Constant | 0.309 | 4.706 |
Dependent variable: lipiodol Deposit (0 =< 50%, 1 =>= 50%).
Independent variable: Gender: 1 = Male, 2 = Female; Child-Pugh class: 1 = A, 2 = B, 3 = C; BCLC: 1 = B, 2 = C; sAg: 1 = Positive, 0 = Negative; Group: 1 = TACE+sorafenib, 2 = TACE;
AFP: 0 =< 200, 1 =>= 200; Tumor size: 0 =< 7 cm, 1 =>= 7 cm; No. of tumors: 0 =< 3, 1 =>=3;
TACE times: 0 =< 3, 1 =>= 3.